Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab for GVHD Prevention in Nonmyeloablative Transplant
NCT00975975Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Sep 2009
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of basiliximab in graft-versus-host disease (GVHD), sponsored by Indiana University School of Medicine. Started Sep 2009; status: completed.
02
Drugs
basiliximab
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00975975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975975.